4//SEC Filing
MCKNIGHT STEVEN L 4
Accession 0001182470-04-000002
CIK 0000889057other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:03 PM ET
Size
30.6 KB
Accession
0001182470-04-000002
Insider Transaction Report
Form 4
TULARIK INCTLRK
MCKNIGHT STEVEN L
Director
Transactions
- Disposition to Issuer
Common Stock
2004-08-13−71,540→ 0 total(indirect: By Trust) - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−8,000→ 0 totalExercise: $25.38Exp: 2010-04-26→ Common Stock (8,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−6,666→ 0 totalExercise: $10.40Exp: 2012-05-16→ Common Stock (6,666 underlying) - Disposition to Issuer
Common Stock
2004-08-13−160,000→ 0 total(indirect: By Trust) - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−18,000→ 0 totalExercise: $18.36Exp: 2011-09-19→ Common Stock (18,000 underlying) - Disposition to Issuer
Common Stock
2004-08-13−238,476→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−100,000→ 0 totalExercise: $4.88Exp: 2013-03-20→ Common Stock (100,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−16,668→ 0 totalExercise: $14.40Exp: 2012-04-17→ Common Stock (16,668 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−10,000→ 0 totalExercise: $5.17Exp: 2013-04-22→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−25,000→ 0 totalExercise: $23.13Exp: 2010-06-07→ Common Stock (25,000 underlying)
Footnotes (13)
- [F1]Disposed of pursuant to merger agreement between issuer and Amgen Inc. in exchange for 107,552 shares of Amgen common stock having a market value of $55.432 per share pursuant to the terms of the merger agreement.
- [F10]This option, which provided for vesting in equal monthly installments over a four-year period until full vest on May 17, 2006, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 3,006 shares of Amgen common stock for $23.06 per share.
- [F11]This option, which provided for vesting in equal monthly installments over a four-year period until full vest on June 18, 2006, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 3,006 shares of Amgen common stock for $17.72 per share.
- [F12]This option, which provided for vesting in equal monthly installments over a four-year period until full vest on March 21, 2007, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 45,100 shares of Amgen common stock for $10.83 per share.
- [F13]This option, which provided for vesting in equal annual installments over a four-year period until full vest on April 23, 2007, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 4,510 shares of Amgen common stock for $11.47 per share.
- [F2]Disposed of pursuant to merger agreement between issuer and Amgen Inc. in exchange for 32,264 shares of Amgen common stock having a market value of $55.432 per share pursuant to the terms of the merger agreement.
- [F3]The Reporting Person disclaims beneficial ownership of these securities, and the filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of such equity securities.
- [F4]Disposed of pursuant to merger agreement between issuer and Amgen Inc. in exchange for 72,160 shares of Amgen common stock having a market value of $55.432 per share pursuant to the terms of the merger agreement.
- [F5]This option, which was fully vested as of April 26, 2004, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 3,608 shares of Amgen common stock for $56.27 per share.
- [F6]This option, which was fully vested as of June 7, 2004, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 11,275 shares of Amgen common stock for $51.28 per share.
- [F7]This option, which provided for vesting in equal annual installments over a four-year period until full vest on April 24, 2005, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 3,608 shares of Amgen common stock for $46.41 per share.
- [F8]This option, which provided for vesting in equal monthly installments beginning September 20, 2001 until full vest on August 20, 2005, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 8,118 shares of Amgen common stock for $40.71 per share.
- [F9]This option, which provided for vesting in equal monthly installments over a four-year period until full vest on April 18, 2006, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 7,517 shares of Amgen common stock for $31.93 per share.
Documents
Issuer
TULARIK INC
CIK 0000889057
Entity typeother
Related Parties
1- filerCIK 0001182470
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:03 PM ET
- Size
- 30.6 KB